List view / Grid view
1 November 2018 | By Iqra Farooq (European Pharmaceutical Review)
Medical cannabis is now avaliable through the NHS, but many are warning about its drawbacks and that it won't be available for those who need it...
18 October 2018 | By Iqra Farooq (European Pharmaceutical Review)
A report has suggested that growth of medical cannabis will reach between $11.9 and $17.1 billion by 2020, and is currently around $5 to $6 billion...
18 October 2018 | By Gilson
Chromatographic purification of natural compounds presents many challenges to scientists because of the complex nature of the starting matrices that are used in the process...
4 October 2018 | By Peak Scientific
Peak Scientific, a global leader in gas generation for analytical laboratories, has recently partnered with Ontario-based Molecular Science Corp. (MSC) to supply nitrogen gas generation systems on their first mobile laboratory aimed at the rapidly expanding cannabis testing and research sector...
28 June 2018 | By European Pharmaceutical Review
The FDA has approved Epidiolex oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy...
27 June 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Pivot Pharmaceuticals Inc. is to begin human clinical trials of PVT-005, the pharmaceutical drug candidate for the treatment of HSDD...
7 June 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Therapix Biosciences Ltd, have announced that the first subject was enrolled for its Phase IIa, a sponsor-initiated clinical trial for Obstructive Sleep Apnea...
21 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Cannabidiol was shown in a new large-scale, randomised, controlled trial to significantly reduce the number of dangerous seizures in patients with a severe form of epilepsy...
24 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers demonstrate hemp's ability to slow cancer growth and uncover mechanism for its cancer-fighting ability...
12 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
GB Sciences, Inc. is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable First-In-Human data on its proprietary cannabis-based therapies...
19 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers are calling for medicinal cannabis to be properly established in our modern medical arsenal...
8 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A naturally occurring compound found in cannabis may help to curb the frequency of epileptic seizures...
14 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have found that cannabis therapy is safe and efficacious for elderly patients who are seeking to address cancer symptoms, Parkinson's disease, Crohn's disease and other medical issues...
25 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Treatment with a pharmaceutical formulation of cannabidiol alongside other anti-epilepsy treatments helped to reduce the number of drop seizures in people with Lennox-Gastaut syndrome...
7 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Neuroscientists have found that cannabidiol reduces symptoms such as impaired memory in adolescent mice simultaneously exposed to THC...
Follow: